Advertisement
Erratum Free access | 10.1172/JCI40905E1
Find articles by Son, N. in: JCI | PubMed | Google Scholar
Find articles by Yu, S. in: JCI | PubMed | Google Scholar
Find articles by Tuinei, J. in: JCI | PubMed | Google Scholar
Find articles by Arai, K. in: JCI | PubMed | Google Scholar
Find articles by Hamai, H. in: JCI | PubMed | Google Scholar
Find articles by Homma, S. in: JCI | PubMed | Google Scholar
Find articles by Shulman, G. in: JCI | PubMed | Google Scholar
Find articles by Abel, E. in: JCI | PubMed | Google Scholar
Find articles by Goldberg, I. in: JCI | PubMed | Google Scholar
Published December 1, 2010 - More info
Excess lipid accumulation in the heart is associated with decreased cardiac function in humans and in animal models. The reasons are unclear, but this is generally believed to result from either toxic effects of intracellular lipids or excessive fatty acid oxidation (FAO). PPARγ expression is increased in the hearts of humans with metabolic syndrome, and use of PPARγ agonists is associated with heart failure. Here, mice with dilated cardiomyopathy due to cardiomyocyte PPARγ overexpression were crossed with PPARα-deficient mice. Surprisingly, this cross led to enhanced expression of several PPAR-regulated genes that mediate fatty acid (FA) uptake/oxidation and triacylglycerol (TAG) synthesis. Although FA oxidation and TAG droplet size were increased, heart function was preserved and survival improved. There was no marked decrease in cardiac levels of triglyceride or the potentially toxic lipids diacylglycerol (DAG) and ceramide. However, long-chain FA coenzyme A (LCCoA) levels were increased, and acylcarnitine content was decreased. Activation of PKCα and PKCδ, apoptosis, ROS levels, and evidence of endoplasmic reticulum stress were also reduced. Thus, partitioning of lipid to storage and oxidation can reverse cardiolipotoxicity despite increased DAG and ceramide levels, suggesting a role for other toxic intermediates such as acylcarnitines in the toxic effects of lipid accumulation in the heart.
Ni-Huiping Son, Shuiqing Yu, Joseph Tuinei, Kotaro Arai, Hiroko Hamai, Shunichi Homma, Gerald I. Shulman, E. Dale Abel, Ira J. Goldberg
Original citation: J Clin Invest.2010;120(10):3443–3454. doi:10.1172/JCI40905.
Citation for this corrigendum: J Clin Invest. 2010;120(12):4583. doi:10.1172/JCI40905E1.
During the preparation of this manuscript, the units for palmitate oxidation in Figure 5A were inadvertently presented incorrectly. The units should be nmol/min/g dry HW.
The JCI regret the error.